HRMY earnings date and last-quarter result: last quarter miss, P/E 13.83. Updated 2026-07-23.
Harmony Biosciences Holdings (HRMY) Research Hub
Harmony Biosciences Holdings (HRMY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 36.83 USD (+1.94%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 13.83, market cap 2.07B. This hub links to the full technical, earnings and options research available for HRMY.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 36.83 USD (+1.94%) |
| 52-week range | 32.25 USD – 43.49 USD |
| Trend regime | Range |
| 14-day RSI | 38.3 (Bearish) |
| Trailing P/E | 13.83 |
| Market cap | 2.07B |
| Dividend yield | 0.00% |
Available research for HRMY
Covered Call on HRMY: how it works, illustrative setup around the real 36.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HRMY: how it works, illustrative setup around the real 36.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HRMY: how it works, illustrative setup around the real 36.83 USD price, max profit/loss, breakeven and when to use it. Educational.
HRMY technical analysis: range, last 36.83 USD, RSI 38.3, 52w range 32.25 USD–43.49 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is HRMY in?
Harmony Biosciences Holdings (HRMY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is HRMY in an uptrend or downtrend?
As of 2026-10-26, HRMY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HRMY's trailing P/E ratio?
HRMY's trailing P/E is 13.83, with a market cap of 2.07B. See the earnings research page for full valuation detail.